罗拉吡坦是高效选择性具有口服活性的 neurokinin NK1 受体抑制剂，Ki值为0.66 nM，为治疗化疗所致恶心呕吐(CINV)的药物。
Pivalaldehyde
(3R,7aR)-3-(tert-butyl)-1-hydroxy-7a-vinyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one
(S)-2-(((Benzyloxy)carbonyl)amino)-2-phenylacetic acid
(R)-2-Methyl-2-propanesulfinamide
Methyl 2-(diethoxyphosphoryl)acetate
Methyltriphenylphosphonium bromide
Benzaldehyde dimethyl acetal
2-Hydroxy-1-phenylethanone
(5S,8S)-8-(((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one
(2R,4S)-Benzyl 5-oxo-2,4-diphenyloxazolidine-3-carboxylate
(3R,7AR)-3-(tert-butyl)-7a-vinyldihydropyrrolo[1,2-c]oxazole-1,5(3H,6H)-dione
(R)-1-(1-(Bromomethoxy)ethyl)-3,5-bis(trifluoromethyl)benzene
(R)-5-((((S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-yl)amino)methyl)-5-vinylpyrrolidin-2-one
(5S,8S)-8-(((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride hydrate
(3R,7aS)-3-(tert-Butyl)dihydropyrrolo[1,2-c]oxazole-1,5(3H,6H)-dione
(S)-1-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-amine fumarate
(S)-5-((Benzylamino)methyl)pyrrolidin-2-one hydrochloride
(3R,7aR)-3-(tert-Butyl)-1,5-dioxohexahydropyrrolo[1,2-c]oxazole-7a-carbaldehyde
(2R,4S)-Benzyl 4-(((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-5-oxo-2,4-diphenyloxazolidine-3-carboxylate
BENZYL ((S)-1-((R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-2-PHENYLBUT-3-EN-2-YL)CARBAMATE
(R)-5-Oxo-2-vinylpyrrolidine-2-carbaldehyde
